Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination
Homo sapiens
12 Downloadable Samples
Illumina HiSeq 2500
Submitter Supplied Information
Description
T84 cells were treated with DMSO, 30nM trametinib (MEKi), 1µM JQ1 (BRD4i) or the combination of trametinib and JQ1 (combo) for 24h. Overall design: 3 replicates per condition were analyzed by RNA-seq.